Hearing JP Morgan Commenting On Dynavax: Given ~30+% Response Rate Shown In Initial 1b/2 Trial Of SD-101 + Pembro Is Confirmed In Full Presentation, Stock Should Be Up ~35+% From Current Levels In Early Trading